Monday 25 June 2018
Contact US    |    Archive
Reuters
4 months ago

BRIEF-Tocagen Receives EMA Orphan Medicinal Product Designation For Toca 511 Toca FC For Glioma Treatment

* TOCAGEN RECEIVES EUROPEAN MEDICINES AGENCY ORPHAN MEDICINAL PRODUCT DESIGNATION FOR TOCA 511 and TOCA FC FOR THE TREATMENT OF GLIOMA Source text for Eikon: Further company coverage:

Read on the original site


هذه الصفحة هي مجرد قاریء تلقائي للأخبار باستخدام خدمة الـ RSS و بأن نشر هذه الأخبار هنا لاتعني تأییدها علی الإطلاق.
Hashtags:   

BRIEF

 | 

Tocagen

 | 

Receives

 | 

EMA

 | 

Orphan

 | 

Medicinal

 | 

Product

 | 

Designation

 | 

For

 | 

Toca

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Categories - Countries
All News
USA